Ati cautat: ATI
ANMDM: Raportarea reactiilor adverse in Romania cunoaste un trend ascendent
Proiect de reorganizarea ANMDM, pus in transparenta decizionala
Protocol terapeutic: H01AC03 – DCI MECASERMIN (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: M09AX07 – DCI NUSINERSENUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC11 – DCI IPILIMUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX52 – DCI VENETOCLAX (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: L01XX42 – DCI PANOBINOSTATUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE33 – DCI PALBOCICLIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC24 – DCI DARATUMUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
